Cargando…

Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis

BACKGROUND: The non-inferiority of combined breast conservation surgery (BCS) and radiotherapy (breast conservation therapy or BCT) compared to mastectomy in sporadic breast cancer cases is well recognised. Uncertainty remains regarding optimal surgical practice in BRCA mutation carriers. AIMS: To e...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, M.G., Davey, C.M., Ryan, É.J., Lowery, A.J., Kerin, M.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887648/
https://www.ncbi.nlm.nih.gov/pubmed/33582622
http://dx.doi.org/10.1016/j.breast.2021.02.001
_version_ 1783652026098384896
author Davey, M.G.
Davey, C.M.
Ryan, É.J.
Lowery, A.J.
Kerin, M.J.
author_facet Davey, M.G.
Davey, C.M.
Ryan, É.J.
Lowery, A.J.
Kerin, M.J.
author_sort Davey, M.G.
collection PubMed
description BACKGROUND: The non-inferiority of combined breast conservation surgery (BCS) and radiotherapy (breast conservation therapy or BCT) compared to mastectomy in sporadic breast cancer cases is well recognised. Uncertainty remains regarding optimal surgical practice in BRCA mutation carriers. AIMS: To evaluate the oncological safety of combined BCT versus mastectomy in BRCA mutation carriers following breast cancer diagnosis. METHODS: A systematic review was performed as per PRISMA and MOOSE guidelines. Observational studies comparing BCS and mastectomy in BRCA carriers were identified. Dichotomous variables were pooled as odds ratios (OR) using the Mantel–Haenszel method. Log hazard ratios (lnHR) for locoregional recurrence (LRR), contralateral breast cancer, disease-free and overall survival and their standard errors were calculated from Kaplan-Meier or cox-regression analyses and pooled using the inverse variance method. RESULTS: Twenty three studies of 3807 patients met inclusion criteria; 2200 (57.7%) were BRCA1 and 1212 (31.8%) were BRCA2 carriers. Median age at diagnosis was 41 years with 96 months follow up. BCS was performed on 2157 (56.7%) while 1408 (41.5%) underwent mastectomy. An increased risk of LRR was observed in patients treated with BCS (HR:4.54, 95% Confidence Interval: 2.77–7.42, P < 0.001, heterogeneity (I(2)) = 0%). However, the risks of contralateral breast cancer (HR:1.51, 95%CI: 0.44–5.11, P = 0.510, I(2) = 80%), disease recurrence (HR:1.16, 95%CI: 0.78–1.72, P = 0.470, I(2) = 44%), disease-specific recurrence (HR:1.58, 95%CI: 0.79–3.15, P = 0.200, I(2) = 38%) and death (HR:1.10, 95%CI: 0.72–1.69, P = 0.660, I(2) = 38%) were equivalent for combined BCT and mastectomy. CONCLUSIONS: Survival outcomes following combined BCT is comparable to mastectomy in BRCA carriers. However, the risk of LRR is increased. Patient counselling should be tailored to incorporate these findings.
format Online
Article
Text
id pubmed-7887648
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78876482021-02-26 Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis Davey, M.G. Davey, C.M. Ryan, É.J. Lowery, A.J. Kerin, M.J. Breast Original Article BACKGROUND: The non-inferiority of combined breast conservation surgery (BCS) and radiotherapy (breast conservation therapy or BCT) compared to mastectomy in sporadic breast cancer cases is well recognised. Uncertainty remains regarding optimal surgical practice in BRCA mutation carriers. AIMS: To evaluate the oncological safety of combined BCT versus mastectomy in BRCA mutation carriers following breast cancer diagnosis. METHODS: A systematic review was performed as per PRISMA and MOOSE guidelines. Observational studies comparing BCS and mastectomy in BRCA carriers were identified. Dichotomous variables were pooled as odds ratios (OR) using the Mantel–Haenszel method. Log hazard ratios (lnHR) for locoregional recurrence (LRR), contralateral breast cancer, disease-free and overall survival and their standard errors were calculated from Kaplan-Meier or cox-regression analyses and pooled using the inverse variance method. RESULTS: Twenty three studies of 3807 patients met inclusion criteria; 2200 (57.7%) were BRCA1 and 1212 (31.8%) were BRCA2 carriers. Median age at diagnosis was 41 years with 96 months follow up. BCS was performed on 2157 (56.7%) while 1408 (41.5%) underwent mastectomy. An increased risk of LRR was observed in patients treated with BCS (HR:4.54, 95% Confidence Interval: 2.77–7.42, P < 0.001, heterogeneity (I(2)) = 0%). However, the risks of contralateral breast cancer (HR:1.51, 95%CI: 0.44–5.11, P = 0.510, I(2) = 80%), disease recurrence (HR:1.16, 95%CI: 0.78–1.72, P = 0.470, I(2) = 44%), disease-specific recurrence (HR:1.58, 95%CI: 0.79–3.15, P = 0.200, I(2) = 38%) and death (HR:1.10, 95%CI: 0.72–1.69, P = 0.660, I(2) = 38%) were equivalent for combined BCT and mastectomy. CONCLUSIONS: Survival outcomes following combined BCT is comparable to mastectomy in BRCA carriers. However, the risk of LRR is increased. Patient counselling should be tailored to incorporate these findings. Elsevier 2021-02-04 /pmc/articles/PMC7887648/ /pubmed/33582622 http://dx.doi.org/10.1016/j.breast.2021.02.001 Text en © 2021 The Author(s) http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Davey, M.G.
Davey, C.M.
Ryan, É.J.
Lowery, A.J.
Kerin, M.J.
Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
title Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
title_full Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
title_fullStr Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
title_full_unstemmed Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
title_short Combined breast conservation therapy versus mastectomy for BRCA mutation carriers – A systematic review and meta-analysis
title_sort combined breast conservation therapy versus mastectomy for brca mutation carriers – a systematic review and meta-analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887648/
https://www.ncbi.nlm.nih.gov/pubmed/33582622
http://dx.doi.org/10.1016/j.breast.2021.02.001
work_keys_str_mv AT daveymg combinedbreastconservationtherapyversusmastectomyforbrcamutationcarriersasystematicreviewandmetaanalysis
AT daveycm combinedbreastconservationtherapyversusmastectomyforbrcamutationcarriersasystematicreviewandmetaanalysis
AT ryanej combinedbreastconservationtherapyversusmastectomyforbrcamutationcarriersasystematicreviewandmetaanalysis
AT loweryaj combinedbreastconservationtherapyversusmastectomyforbrcamutationcarriersasystematicreviewandmetaanalysis
AT kerinmj combinedbreastconservationtherapyversusmastectomyforbrcamutationcarriersasystematicreviewandmetaanalysis